Kim Lufkin is a communications officer at GHTC.
What comes to mind when you think of drug development?
Ever feel like you can’t see the forest for the trees?
Ever feel like you can’t see the forest for the trees? In everyday life, it’s easy to get bogged down in details. This can be especially true in a field like drug development where it can take ten years (under the best circumstances) or more to see your work come to fruition.
In this guest post, PATH’s Drug Development program asked its staff to reflect on the question, “What comes to mind when you think of drug development?” A few of their responses appear below. This is the third and final post in a three-part series on drug development. You can read part 1 here, and part 2 here.